Journal articles on the topic 'Homozygous Familial Hypercholesterolemia'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'Homozygous Familial Hypercholesterolemia.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Wierzbicki, Anthony S. "Homozygous familial hypercholesterolemia." Clinical Lipidology 8, no. 4 (2013): 407–9. http://dx.doi.org/10.2217/clp.13.37.
Full textParihar, RaviKumar, Ghanshyam Saini, and Mohd. Razaq. "Homozygous familial hypercholesterolemia." Indian Journal of Endocrinology and Metabolism 16, no. 4 (2012): 643. http://dx.doi.org/10.4103/2230-8210.98032.
Full textGenest, Jacques, and Marc-André Lavoie. "Homozygous Familial Hypercholesterolemia." New England Journal of Medicine 341, no. 7 (1999): 490. http://dx.doi.org/10.1056/nejm199908123410705.
Full textBajaj, Archna, and Marina Cuchel. "Homozygous familial hypercholesterolemia." Current Opinion in Lipidology 31, no. 3 (2020): 119–24. http://dx.doi.org/10.1097/mol.0000000000000677.
Full textRaal, Frederick J. "Homozygous Familial Hypercholesterolemia." JACC: Advances 2, no. 3 (2023): 100324. http://dx.doi.org/10.1016/j.jacadv.2023.100324.
Full textManappallil, RobinGeorge, Ashokan Nambiar, VG Pradeep Kumar, and Avinash Sarpamale. "Homozygous familial hypercholesterolemia with valvulopathy." Journal of Clinical and Preventive Cardiology 8, no. 1 (2019): 34. http://dx.doi.org/10.4103/jcpc.jcpc_26_18.
Full textBrown, L., I. Ruel, A. Bélanger, et al. "HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA IN CANADA." Canadian Journal of Cardiology 37, no. 10 (2021): S23. http://dx.doi.org/10.1016/j.cjca.2021.07.056.
Full textBrown, L., I. Ruel, I. Iatan, et al. "HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA IN CANADA." Canadian Journal of Cardiology 38, no. 10 (2022): S121—S122. http://dx.doi.org/10.1016/j.cjca.2022.08.043.
Full textSperlongano, Simona, Felice Gragnano, Francesco Natale, et al. "Lomitapide in homozygous familial hypercholesterolemia." Journal of Cardiovascular Medicine 19, no. 3 (2018): 83–90. http://dx.doi.org/10.2459/jcm.0000000000000620.
Full textFrance, Michael, Jonathan Schofield, See Kwok, and Handrean Soran. "Treatment of homozygous familial hypercholesterolemia." Clinical Lipidology 9, no. 1 (2014): 101–18. http://dx.doi.org/10.2217/clp.13.79.
Full textHill, Suvimol C., Jeffrey M. Hoeg, and Nilo A. Avila. "Nephrocalcinosis in Homozygous Familial Hypercholesterolemia." Journal of Computer Assisted Tomography 15, no. 1 (1991): 101–3. http://dx.doi.org/10.1097/00004728-199101000-00015.
Full textRaal, Frederick J., Robert S. Rosenson, Laurens F. Reeskamp, et al. "Evinacumab for Homozygous Familial Hypercholesterolemia." New England Journal of Medicine 383, no. 8 (2020): 711–20. http://dx.doi.org/10.1056/nejmoa2004215.
Full textDi Taranto, M. D., C. Giacobbe, A. Morrone, et al. "Homozygous Familial Hypercholesterolemia in Campania." Nutrition, Metabolism and Cardiovascular Diseases 27, no. 1 (2017): e20. http://dx.doi.org/10.1016/j.numecd.2016.11.053.
Full textSantos, Raul D. "Homozygous familial hypercholesterolemia: phenotype rules!" Atherosclerosis 248 (May 2016): 252–54. http://dx.doi.org/10.1016/j.atherosclerosis.2016.03.015.
Full textSánchez-Hernández, Rosa M., Fernando Civeira, Marianne Stef, et al. "Homozygous Familial Hypercholesterolemia in Spain." Circulation: Cardiovascular Genetics 9, no. 6 (2016): 504–10. http://dx.doi.org/10.1161/circgenetics.116.001545.
Full textMarais, A. D., D. J. Blom, and J. C. Firth. "Statins in homozygous familial hypercholesterolemia." Current Atherosclerosis Reports 4, no. 1 (2002): 19–25. http://dx.doi.org/10.1007/s11883-002-0058-7.
Full textCegla, Jaimini, Shahenaz Walji, Lucy Barton, Clare Neuwirth, and Gilbert R. Thompson. "Treatment of Homozygous Familial Hypercholesterolemia." JACC: Advances 4, no. 5 (2025): 101708. https://doi.org/10.1016/j.jacadv.2025.101708.
Full textProute, Matthew, Paige Seepaulsingh, Tanay Modi, et al. "Beyond homozygous familial hypercholesterolemia – emerging therapy for severe familial hypercholesterolemia phenotypes." Journal of Clinical Lipidology 19, no. 3 (2025): e77. https://doi.org/10.1016/j.jacl.2025.04.108.
Full textRiche, Daniel M., and Honey E. East. "Xanthomas Associated with Homozygous Familial Hypercholesterolemia." Pharmacotherapy 29, no. 12 (2009): 1496. http://dx.doi.org/10.1592/phco.29.12.1496.
Full textGossios, Thomas, Ioanna Zografou, Veta Simoulidou, Athina Pirpassopoulou, Konstantinos Christou, and Asterios Karagiannis. "Multimodal Treatment of Homozygous Familial Hypercholesterolemia." Current Pharmaceutical Design 24, no. 31 (2019): 3616–21. http://dx.doi.org/10.2174/1381612824666181009095522.
Full textМеситская, Д. Ф., М. С. Балашова, Н. А. Жученко, and А. Е. Потапкина. "Clinical case of homozygous familial hypercholesterolemia." Nauchno-prakticheskii zhurnal «Medicinskaia genetika», no. 5(214) (May 29, 2020): 39–40. http://dx.doi.org/10.25557/2073-7998.2020.05.39-40.
Full textKawamura, Tomonori, Kenji Mogi, Yoshinori Enomoto, Manabu Sakurai, Kaoru Matsuura, and Yoshiharu Takahara. "Cardiac Surgery in Homozygous Familial Hypercholesterolemia." Japanese Journal of Cardiovascular Surgery 42, no. 4 (2013): 307–11. http://dx.doi.org/10.4326/jjcvs.42.307.
Full textIshigaki, Yasushi, Naoki Kawagishi, Yutaka Hasegawa, et al. "Liver Transplantation for Homozygous Familial Hypercholesterolemia." Journal of Atherosclerosis and Thrombosis 26, no. 2 (2019): 121–27. http://dx.doi.org/10.5551/jat.rv17029.
Full textMoorthy, Nagaraja, Prabhavathi Bhat, ManjunathC Nanjappa, and Rajiv Ananthakrishna. "Xanthoma tuberosum in homozygous familial hypercholesterolemia." Annals of Pediatric Cardiology 7, no. 2 (2014): 118. http://dx.doi.org/10.4103/0974-2069.132479.
Full textGaudet, Daniel, Daniel A. Gipe, Robert Pordy, et al. "ANGPTL3 Inhibition in Homozygous Familial Hypercholesterolemia." New England Journal of Medicine 377, no. 3 (2017): 296–97. http://dx.doi.org/10.1056/nejmc1705994.
Full textTeruel, J. L., and M. A. Lasunción. "Cutaneous Xanthomas in Homozygous Familial Hypercholesterolemia." New England Journal of Medicine 332, no. 17 (1995): 1137. http://dx.doi.org/10.1056/nejm199504273321705.
Full textMarais, Adrian David, Jean Catherine Firth, and Dirk Jacobus Blom. "Homozygous Familial Hypercholesterolemia and Its Management." Seminars in Vascular Medicine 4, no. 01 (2004): 43–50. http://dx.doi.org/10.1055/s-2004-822985.
Full textJones, Elizabeth, Irwin M. Feuerstein, Eben Tucker, Ronald M. Summers, Thomas L. Spray, and Jeffrey M. Hoeg. "Aortic Hypoplasia in Homozygous Familial Hypercholesterolemia." American Journal of Cardiology 81, no. 10 (1998): 1242–43. http://dx.doi.org/10.1016/s0002-9149(98)00114-3.
Full textTully, Lisa, Arthur Schwartzbard, and James A. Underberg. "Contemporary Treatment of Homozygous Familial Hypercholesterolemia." Journal of Clinical Lipidology 8, no. 3 (2014): 330–31. http://dx.doi.org/10.1016/j.jacl.2014.02.057.
Full textGidding, Samuel S. "Managing Patients With Homozygous Familial Hypercholesterolemia." Journal of the American College of Cardiology 70, no. 9 (2017): 1171–72. http://dx.doi.org/10.1016/j.jacc.2017.06.057.
Full textThompson, Gilbert R. "Cardiac catheterization in homozygous familial hypercholesterolemia." Atherosclerosis 66, no. 1-2 (1987): 173. http://dx.doi.org/10.1016/0021-9150(87)90195-x.
Full textKyselak, Ondrej, Tomas Freiberger, Jan Kovar, Lukas Tichy, and Vladimir Soska. "Atypical phenotype of homozygous familial hypercholesterolemia." Atherosclerosis 263 (August 2017): e224. http://dx.doi.org/10.1016/j.atherosclerosis.2017.06.732.
Full textWidhalm, Kurt, Ina Michel Benke, Michael Fritz, et al. "Homozygous familial hypercholesterolemia: Summarized case reports." Atherosclerosis 257 (February 2017): 86–89. http://dx.doi.org/10.1016/j.atherosclerosis.2017.01.002.
Full textKraft, H. G., A. Lingenhel, F. J. Raal, M. Hohenegger, and G. Utermann. "Lipoprotein(a) in Homozygous Familial Hypercholesterolemia." Arteriosclerosis, Thrombosis, and Vascular Biology 20, no. 2 (2000): 522–28. http://dx.doi.org/10.1161/01.atv.20.2.522.
Full textThompson, Gilbert R. "PCSK9 Inhibitors for Homozygous Familial Hypercholesterolemia." Journal of the American College of Cardiology 76, no. 2 (2020): 143–45. http://dx.doi.org/10.1016/j.jacc.2020.05.033.
Full textToth, Peter P. "Evinacumab Therapy for Homozygous Familial Hypercholesterolemia." JACC: Advances 2, no. 9 (2023): 100646. http://dx.doi.org/10.1016/j.jacadv.2023.100646.
Full textCesmat, Andrew, Jessica Willis, Ellina Max, and Ross J. Simpson. "PROLONGED SURVIVAL IN HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA." Journal of the American College of Cardiology 85, no. 12 (2025): 2891. https://doi.org/10.1016/s0735-1097(25)03375-3.
Full textReeskamp, Laurens F., John S. Millar, Liya Wu, et al. "ANGPTL3 Inhibition With Evinacumab Results in Faster Clearance of IDL and LDL apoB in Patients With Homozygous Familial Hypercholesterolemia—Brief Report." Arteriosclerosis, Thrombosis, and Vascular Biology 41, no. 5 (2021): 1753–59. http://dx.doi.org/10.1161/atvbaha.120.315204.
Full textTunçer, Eylem. "Coronary revascularization in a 13 year old patient with homozygous familial hypercholesterolemia." Turkish Journal of Thoracic and Cardiovascular Surgery 22, no. 1 (2014): 168–70. http://dx.doi.org/10.5606/tgkdc.dergisi.2014.8013.
Full textReeskamp, Laurens F., Nick S. Nurmohamed, Michiel J. Bom, et al. "Marked plaque regression in homozygous familial hypercholesterolemia." Atherosclerosis 327 (June 2021): 13–17. http://dx.doi.org/10.1016/j.atherosclerosis.2021.04.014.
Full textShotwell, Matthew K., Mounica Vorla, and Dinesh K. Kalra. "Very High Cholesterol Mimicking Homozygous Familial Hypercholesterolemia." Circulation 146, no. 15 (2022): 1182–88. http://dx.doi.org/10.1161/circulationaha.122.061578.
Full textJeraj, Natasha, Shih-Han S. Huang, Brooke A. Kennedy, and Robert A. Hegele. "Treatment of Homozygous Familial Hypercholesterolemia With Evinacumab." CJC Open 4, no. 3 (2022): 347–49. http://dx.doi.org/10.1016/j.cjco.2021.11.009.
Full textMastrolorenzo, Antonio, Antonietta D’Errico, Piera Pierotti, Margherita Vannucchi, Stefano Giannini, and Fiammetta Fossi. "Pleomorphic cutaneous xanthomas disclosing homozygous familial hypercholesterolemia." World Journal of Dermatology 6, no. 4 (2017): 59–65. http://dx.doi.org/10.5314/wjd.v6.i4.59.
Full textSelvan, J. P., B. Uthaman, L. Abushaban, and R. Jebaraj. "Homozygous Familial Hypercholesterolemia with Generalized Arterial Disease." Medical Principles and Practice 16, no. 1 (2006): 75–78. http://dx.doi.org/10.1159/000096146.
Full textGidding, Samuel S. "The complexities of homozygous familial hypercholesterolemia management." Pediatric Transplantation 20, no. 8 (2016): 1020–21. http://dx.doi.org/10.1111/petr.12812.
Full textDrogari, E., P. Progias, A. Skouma, M. Elisaf, and V. Mollaki. "MS52 HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA (FH) IN GREECE." Atherosclerosis Supplements 11, no. 2 (2010): 120. http://dx.doi.org/10.1016/s1567-5688(10)70553-5.
Full textBanerjee, Ambuja, Latifah Alothman, Patrick Couture, et al. "The Lifelong Burden of Homozygous Familial Hypercholesterolemia." Canadian Journal of Cardiology 35, no. 10 (2019): 1419.e1–1419.e4. http://dx.doi.org/10.1016/j.cjca.2019.06.009.
Full textJames, R. W., B. Martin, D. Pometta, et al. "Apolipoprotein B metabolism in homozygous familial hypercholesterolemia." Journal of Lipid Research 30, no. 2 (1989): 159–69. http://dx.doi.org/10.1016/s0022-2275(20)38378-4.
Full textFrancis, G. A. "Cerebral cholesterol granuloma in homozygous familial hypercholesterolemia." Canadian Medical Association Journal 172, no. 4 (2005): 495–97. http://dx.doi.org/10.1503/cmaj.1041152.
Full textSánchez-Hernández, R. M., M. Stef, S. Perez-Calahorra, et al. "Characteristics of homozygous familial hypercholesterolemia in Spain." Atherosclerosis 252 (September 2016): e203. http://dx.doi.org/10.1016/j.atherosclerosis.2016.07.126.
Full text